Bright Minds Biosciences Inc (DRUG.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 18 | 18 | 18 | 18 | N/A |
| Accounts receivable | 67 | -70 | 26 | 97 | -91 |
| Other Working Capital | -255 | -322 | 479 | -844 | 844 |
| Other Operating Activity | -1,027 | -1,276 | -2,036 | -1,935 | -2,881 |
| Operating Cash Flow | $-1,198 | $-1,651 | $-1,513 | $-2,664 | $-2,129 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -22 | -21 | -21 | -21 | 25 |
| Common Stock Issued | 0 | 0 | 0 | 1,218 | 4,035 |
| Other Financing Activity | 0 | 0 | 0 | 1,058 | 1,005 |
| Financing Cash Flow | $-22 | $-21 | $-21 | $2,254 | $5,064 |
| Exchange Rate Effect | -163 | 130 | -5 | -7 | 51 |
| Beginning Cash Position | 8,131 | 9,672 | 11,212 | 11,628 | 8,641 |
| End Cash Position | 6,748 | 8,131 | 9,672 | 11,212 | 11,628 |
| Net Cash Flow | $-1,219 | $-1,672 | $-1,534 | $-409 | $2,936 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,198 | -1,651 | -1,513 | -2,664 | -2,129 |
| Free Cash Flow | -1,198 | -1,651 | -1,513 | -2,664 | -2,129 |